Intrathecal Therapy Versus Standard Care for Severe Cancer Pain | MicrobiomeTrials← Back to trialsNCT07691840
Intrathecal Therapy Versus Standard Care for Severe Cancer Pain
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2029-10-31
Enrollment target: 72 participants Locations- UZ Brussel, Jette, Belgium
Other microbiome trials you might be interested in
Angelman Syndrome
The primary objective of the study is to evaluate the long-term safety profile of GTX-102 in participants with Angelman …
Los Angeles, United StatesCompleted Feb 2029
Intrathecal Pump Refill
The IMPROVE study is a randomized, controlled, cross-over trial designed to compare intrathecal pump refills performed a…
Jette, BelgiumEst. completion Oct 1, 2028
Tissue Plasminogen ActivatorIntraventricular Brain Hemorrhage
The study aims to investigate the effect of continuous tPA irrigation into the ventricles. Investigators believe it may …
Lexington, United StatesEst. completion May 31, 2028